Du, Y., Zhou, L., Lin, Y., Yin, K., Yin, W., & Lu, J. (2019). Polymorphisms in microRNA let-7 binding sites of the HIF1AN and CLDN12 genes can predict pathologic complete response to taxane- and platinum-based neoadjuvant chemotherapy in breast cancer. Ann Transl Med.
Chicago-стиль цитированияDu, Yueyao, Liheng Zhou, Yanping Lin, Kai Yin, Wenjin Yin, and Jinsong Lu. "Polymorphisms in MicroRNA Let-7 Binding Sites of the HIF1AN and CLDN12 Genes Can Predict Pathologic Complete Response to Taxane- and Platinum-based Neoadjuvant Chemotherapy in Breast Cancer." Ann Transl Med 2019.
MLA-цитированиеDu, Yueyao, et al. "Polymorphisms in MicroRNA Let-7 Binding Sites of the HIF1AN and CLDN12 Genes Can Predict Pathologic Complete Response to Taxane- and Platinum-based Neoadjuvant Chemotherapy in Breast Cancer." Ann Transl Med 2019.